GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » Change In Receivables

Brawn Biotech (BOM:530207) Change In Receivables : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech Change In Receivables?

Brawn Biotech's change in receivables for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means Brawn Biotech's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Brawn Biotech's change in receivables for the fiscal year that ended in Mar. 2024 was ₹13.8 Mil. It means Brawn Biotech's Accounts Receivable declined by ₹13.8 Mil from Mar. 2023 to Mar. 2024 .

Brawn Biotech's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹38.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Brawn Biotech's Days Sales Outstanding for the three months ended in Mar. 2024 was 102.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Brawn Biotech's liquidation value for the three months ended in Mar. 2024 was ₹-20.8 Mil.


Brawn Biotech Change In Receivables Historical Data

The historical data trend for Brawn Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech Change In Receivables Chart

Brawn Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.23 63.29 51.01 -9.42 13.83

Brawn Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Brawn Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech  (BOM:530207) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Brawn Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=38.83/34.465*91
=102.81

2. In Ben Graham's calculation of liquidation value, Brawn Biotech's accounts receivable are only considered to be worth 75% of book value:

Brawn Biotech's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=15.238-95.238+0.75 * 38.83+0.5 * 60.166
=-20.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Brawn Biotech (BOM:530207) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines